bristol-myers squibb co (BMY:New York)
Elliott Sigal M.D., Ph.D.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 4 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Elliott Sigal, M.D, Ph.D, has been the Venture Partner and Senior Advisor of New Enterprise Associates since January 9, 2014 and consults for select biotechnology companies. Dr. Sigal has more than 25 years of experience spanning drug discovery, drug development, corporate strategy and general management. He served as Chief Scientific Officer, Executive Vice President and President of R&D of Bristol-Myers Squibb Pharmaceuticals Limited from 2004 to 2013. He served ...
345 Park AvenuePhone: 212-546-4000
New York, New York 10154
Board Members Memberships*
Director, Member of Nutrition Science & Technology Committee and Member of Risk Management & Compliance Committee
Non-Executive Director and Member of Corporate Governance & Nominating Committee
Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Scientific & Technology Committee
The University of Chicago
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|